Join us on November 25–27 for a packed schedule of talks, all given by prestigious speakers on a diversity of topics related to chemical biology and early drug discovery. Our Autumn Training School is free of charge and fully virtual, so that scientists from around the world may join the discussions.
Our target group? Everyone with an interest in chemical biology and/or early drug discovery! Students and early-career scientists are especially welcome, to learn about the fundamentals of research in these fields and network with our distinguished guest speakers during the training Q&A sessions.
Participation fee: free of charge
Please regsiter here: https://forms.office.com/e/uhNdMgGku2
Welcome and Introduction9:30 - 10:00 | EU-OPENSCREEN ERIC Screening and Medicinal Chemistry ServicesPhil GribbonDirector General EU-OPENSCREEN ERIC |
1st Session10:00 - 10:45 | Data analysis/data reproducibility – Principles of open data and open-source toolsArrate Munoz Barrutia (AI4Life)Associated Professor, Bioengineering and Aerospace Engineering Department, Universidad Carlos III de Madrid, Spain |
10:45 | Break (15') |
2nd Session11:00 - 11:45 | NPs and drug discovery making a link to the EUREMAP bioprospecting pipelines approachesOlga GenilloudScientific Director of Fundación MEDINA, Spain |
11:45 | Lunch Break (60') |
3rd Session12:45 - 13:30 | Marine bioprospecting (EUREMAP)Jeanette Hammer AndersenProfessor in marine bioprospecting and head of the natural products platform Marbio, The Arctic University of Norway (UiT), Norway |
4th Session13:30 - 14:15 | Antibiotic drug discovery in the frame of ENABLE projectFrederik DerooseChief knowledge Officer, AGILeBiotics, Netherlands |
5th Session14:15 - 15:00 | High-content screeningBrinton Seashore-LudlowGroup leader Biology team, Chemical Biology Consortium Sweden (CBCS) |
1st Session09:30 - 10:15 | Gut microbiome - drug interactionsSarela García SantamariaGroup Leader (Human Microbiota – Xenobiotics Interactions Lab), ITQB-Nova, Oeiras, Portugal |
2nd Session10:15 - 11:00 | Advanced disease models for screening (IMPULSE)Miguel ManoGroup Leader, Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Portugal & King’s College London, United Kingdom |
11:00 | Break (15') |
3rd Session11:15 - 12:00 | Polypharmacology: From off-targets to multitarget drugsInés ArdaoBiotechnologist, Innopharma Pharmacogenomics Platform, University of Santiago de Compostela (USC), Spain Geert DaudeyBiochemist, Innopharma Pharmacogenomics Platform, University of Santiago de Compostela (USC), Spain |
12:00 | Lunch Break (60') |
4th Session13:00 - 13:45 | Is it possible to do chemical biology as a platform?Haim BarrHead Of Unit at Wohl Institute of Drug Discovery, Weizmann Institute of Science, Israel |
5th Session13:45 - 14:30 | Chemoproteomics (Histone deacetylases)Guillaume MedardHead of Proteomics Core Facility, National and Kapodistrian University of Athens, Greece |
6th Session14:30 - 15:15 | Developing a Target Product Profile for a drug discovery projectSheraz GulHead of Innovation Area Drug Screening & Compound Repurposing, Fraunhofer Institute for Translational Medicine and Pharmacology, Germany |
1st Session09:30 - 10:15 | The European Chemical Biology Database (ECBD)Ctibor ŠkutaHead of the cheminformatics & software development unit, CZ-OPENSCREEN |
2nd Session10:15 - 11:00 | Chemoproteomic characterisation of small molecule degradersStephanie WilhelmChair of Proteomics and Bioanalytics, TU Munich (TUM), Germany |
11:00 | Break (15') |
3rd Session11:15 - 12:00 | BioImage.IO: Model Zoo in Action: No-Code AI Tools for Bioimage ProcessingCarlos Javier Garcia Lopez de Haro (AI4Life)Senior Scientist, Bioimage Analysis Unit, Institut Pasteur, Université Paris Cité, France |
12:00 | Lunch Break (60') |
4th Session13:00 - 13:45 | Assay development and optimizationPepo BreaHead of HTS Unit BioFarma Research Group, University of Santiago de Compostela (USC), Spain |
5th Session13:45 - 14:30 | Omics-based Biomarkers Detection from webtoolsFrancisco GarcíaGroup Leader, Computational Biomedicine Lab,Centro de Investigación Príncipe Felipe (CIPF), Spain |